Automation index

How much of a Pathologist’s job can AI already do?

A first slice and a code come earlier. Putting the diagnosis the chemo depends on do not.

This percentage does not predict how many people will lose their jobs.

Task comparison

IS WORK OVER?

30%

AI can already do 30% of this job.

#44 / 623

Pathologist

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
Grossing, embedding and the first trim. Estimate No public source provides a precise figure. This is our estimate.	18%	48%	+8.6
Read stains, IHC and a template report. Estimate No public source provides a precise figure. This is our estimate.	16%	52%	+8.3
The hard case, the second look and the frozen section. Estimate No public source provides a precise figure. This is our estimate.	18%	18%	+3.2
Board, the surgeon on the phone and the margin. Estimate No public source provides a precise figure. This is our estimate.	16%	28%	+4.5
Cytology, autopsy and the specimen that arrives late. Estimate No public source provides a precise figure. This is our estimate.	16%	22%	+3.5
Signing the diagnosis and what the patient is playing for. Estimate No public source provides a precise figure. This is our estimate.	16%	14%	+2.2
Total	100%		30%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low

IS WORK OVER?

27%

#168 / 623

Nuclear medicine physician

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
PET, SPECT protocols and a stock report. Estimate No public source provides a precise figure. This is our estimate.	18%	52%	+9.4
Order dose, timing and preparation. Estimate No public source provides a precise figure. This is our estimate.	16%	28%	+4.5
Give the isotope and watch the reaction. Estimate No public source provides a precise figure. This is our estimate.	18%	14%	+2.5
Clinic, the cancer that returns and the family. Estimate No public source provides a precise figure. This is our estimate.	16%	22%	+3.5
Quality, waste and radiation protection. Estimate No public source provides a precise figure. This is our estimate.	16%	32%	+5.1
Signing the study and the dose you cannot repeat. Estimate No public source provides a precise figure. This is our estimate.	16%	12%	+1.9
Total	100%		27%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low